ABSTRACT
Introduction Indirect laryngoscopy has become a widely accepted method for learning the techniques of airway management. The incorporation of small, less expensive, and yet more reliable video cameras in laryngoscopes has given the process of laryngoscopy and intubation a big leap. The King Vision video laryngoscope (Medline Industries, USA) has demonstrated promise in several settings while the Linscope video laryngoscope (Centrum, Turkey) is a newly launched device and no literature is available to the best of our knowledge. Therefore, we aimed to compare the performance of the Linscope video laryngoscope (VL) and King Vision video laryngoscope. Method This is a randomized controlled trial study. Seventy patients, after approval from the institute's ethical clearance, were divided into two groups. In Group A, patients were intubated with Linscope VL and in Group B patients were intubated with King Vision VL as per the protocol. The primary outcome measure was the duration of tracheal intubation. Secondary outcomes were measured by the number of attempts, ease of intubation, and glottic view. Results Both Linscope VL and King Vision VL groups were comparable in terms of mean intubation time (20.34 s vs. 19.45 s). The endotracheal intubation with both devices was 100% successful at the first attempt. Both the devices provided a percentage of glottic opening (POGO) score of > 70% and a clear vision of the glottis. The POGO score obtained with King Vision VL was 83.57 ± 11.41% and with Linscope VL was 87.85 ± 10.31%. POGO score was greater with Linscope VL compared to King Vision VL, but the difference was not statistically significant (p-value>0.05). Conclusion King Vision demonstrated shorter intubation time and fewer optimization maneuvers. Both devices achieved a 100% success rate on the first attempt. While both devices are viable first-line options, King Vision's well-established efficacy in the literature suggests its preference over Linscope till extensive evidence is available in the future.
ABSTRACT
Direct Torque Control (DTC) scheme introduces a robust and simple control of electrical drive. However, its shortcomings such as broad torque ripple and variable switching frequency have offered several improvements like Space Vector Modulation (SVM) strategy, multilevel inverter (MLI) topology, etc. The conventional DTC which is fed by the two-level inverter has limited voltage vector, results in some difficulties to optimize the operation, especially at low operating speed. In contrast to MLI, the abundant of voltage vector has provided various amplitudes and angles that can overcome the problem of conventional DTC. Thus, this paper introduces the selected optimal voltage vector obtained from five-level Cascaded H-Bridge (CHB) inverter that employs in DTC hysteresis-based to achieve better optimization that similar to the DTC-SVM. Initially, the research work begins with an investigation on the performance comparison between a DTC hysteresis-based between two-level inverter (conventional method) and a five-level CHB inverter (proposed method). Here, a DC generator acted as a load is employed to control the operating speed instead of the speed controller (speed controller is negligible). Hence, the DTC method is optimized by minimizing the torque ripple as well as retaining the torque control capability at constant torque region on several operating speed. The selected optimal vector from the look-up table DTC of five-level CHB inverter must be dynamically appropriate to any change of torque (increased or decreased torque). For simplicity, this paper will only discuss the experimental results for both topologies of drive system. From the experimental results, it is verified that the torque ripples by the proposed method have achieved 10% and 50% reduction at high and low operating speed respectively. It is found that the DTC hysteresis-based result simpler control method than DTC-SVM while maintaining similar output performance.
ABSTRACT
Electrochemical biosensors have shown great potential in the medical diagnosis field. The performance of electrochemical biosensors depends on the sensing materials used. ZnO nanostructures play important roles as the active sites where biological events occur, subsequently defining the sensitivity and stability of the device. ZnO nanostructures have been synthesized into four different dimensional formations, which are zero dimensional (nanoparticles and quantum dots), one dimensional (nanorods, nanotubes, nanofibers, and nanowires), two dimensional (nanosheets, nanoflakes, nanodiscs, and nanowalls) and three dimensional (hollow spheres and nanoflowers). The zero-dimensional nanostructures could be utilized for creating more active sites with a larger surface area. Meanwhile, one-dimensional nanostructures provide a direct and stable pathway for rapid electron transport. Two-dimensional nanostructures possess a unique polar surface for enhancing the immobilization process. Finally, three-dimensional nanostructures create extra surface area because of their geometric volume. The sensing performance of each of these morphologies toward the bio-analyte level makes ZnO nanostructures a suitable candidate to be applied as active sites in electrochemical biosensors for medical diagnostic purposes. This review highlights recent advances in various dimensions of ZnO nanostructures towards electrochemical biosensor applications.
